Burstein Jennifer 4
4 · Stoke Therapeutics, Inc. · Filed Jun 25, 2021
Insider Transaction Report
Form 4
Burstein Jennifer
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-06-08+11,650→ 11,650 totalExercise: $40.37Exp: 2031-06-07→ Common Stock (11,650 underlying)
Footnotes (1)
- [F1]The option shall fully vest on June 8, 2022 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.